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Most murine C-type viruses are endogenous to a variety of inbred strains of mice and 
have been classified into two groups of viruses based on host range (1). By hybridization 
of viral cDNA to cell DNA, sequences homologous to the xenotropic virus isolates have 
been detected in all the strains examined (2). In contrast, comparable experiments using 
cDNA from the ecotropic AKR Gross-type of virus have demonstrated that some strains of 
mice lack a portion (<50%) of the viral genome (3). Consistent with these data, strains 
lacking the complete AKR MuLV genome have never been shown to produce a complete 
infectious Gross- or AKR-type virus. These results therefore suggest that most strains of 
mice could be expected to express all the antigens associated with a complete xenotropic 
virus and at least a portion of the AKR or Gross viral antigens. 
In several recent studies, the expression of viral antigens in the absence of overt virus 
expression has been suggested (4, 5). Such observations have led to the hypothesis that 
there exists "noncoordinate" regulation of the expression of viral antigens, and that such 
expression  supports  the  notion  that  oncornaviruses  play  a  role  in  development  and 
differentiation (6, 7).  Unfortunately, such conclusions have not been warranted for two 
reasons. First, the assays used to date to detect the expression of viral antigens have been 
either immune precipitation or competition assays using antisera with broad reactivity. 
Thus, no clear conclusions can be made as to the homology of the cellular antigens with 
viral antigens. Second, the results could not distinguish between expression of a cellular 
gene  with  close  homology  to  viral  antigens  and  expression  of sequences  physically 
associated with the complete viral genome. Thus, neither the structural homology of the 
antigens to viral proteins nor the relationship of the genes for these antigens to viral 
sequences is known. 
During  the  last  2  yr  we  have  extensively  analyzed  the  role  of endogenous 
ecotropic, AKR-type viruses in radiation leukemia of mice. The results show no 
seroepidemiological  relationship  between these  viruses and  leukemia,  and  no 
overt virus expression in most of the thymomas (8, 9). Nevertheless, to further 
examine  virus  expression  during  the  course  of  thymoma  development,  we 
extensively  examined  the  major  lymphoid  populations  and  other  tissues  by 
competition radioimmune  assays for viral antigens.  The results  from some of 
these experiments are reported here and demonstrate that an antigen indistin- 
guishable from the AKR viral gp71 by homologous competition assays is consti- 
tutively  expressed  in  bone  marrow  cells  of  all  mice  examined;  an  antigen 
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indistinguishable from the xenotropic gp71 is expressed in the sera of most mice 
examined; and, the expression of either of these antigens is independent of any 
apparent overt virus expression. 
Materials and Methods 
Experimental Animals.  With the  exception  of 129,  SWR,  and  A  strains,  all  of the  mouse 
strains and the Fischer 344/N  rats were bred at the  Central Animal Facility of the Frederick 
Cancer Research Center. These animals were maintained under specific pathogen-free conditions 
until used. The 129, SWR, and A strains were obtained from The Jackson Laboratory, Bar Harbor, 
Maine. The wild mice were kindly provided by Dr. Donald Fine of the Frederick Cancer Research 
Center. 
Preparation of Tissues and Homogenates.  Bone marrow was expressed from femurs and tibiae 
with Ham's F-12 medium, and washed once with Ham's F-12 by centrifugation at 600 g  for 10 rain. 
Thymocytes, splenocytes, and lymph node cells were prepared by teasing the tissues in Ham's F- 
12, followed by lysing erythrocytes in 0.83% (wt/vol) NH4C1.  The cells were washed as above. All 
cell pellets were kept at -20°C until used. 
The cells were resuspended in 100/~1 of 0.01 M sodium phosphate buffer, pH 7.0, and allowed to 
swell for 5-10 min. The suspensions wree homogenized in  1-ml capacity Kontes tissue grinders 
(Kontes Co., Vineland, N. J.). Two additional homogenization steps followed the additions of 100 
~1 of 0.01 M Tris-HC1,  1 M KC1, and 1% (wt/vol) Triton-X-100, pH 7,5 (TKT buffer)  1 and 500 ~1 of 
0.01 M Tris-HC1,  0.1 M  NaC1,  0.001 M  EDTA,  and 0.01% (wt/vol) Triton-X-100, pH 7.5 (TNET). 
The resulting homogenates were centrifuged at 25,000 g  for 20 rain, after which the supernates 
were removed and stored at  -20°C  until used.  Protein concentrations in the homogenates were 
assayed by the method of Lowry et al.  (10). 
Preparation  of Viral Reagents.  AKR,  Friend, and BALB(X) viruses and viral proteins were 
isolated and purified, and specific antisera were made in rabbits as previously described (11,  12). 
Viral proteins were iodinated using Na12~I and chloramine-T according to the method of Green- 
wood et al.  (13). 
Competition  Radioimmune Assays.  Tissue  extracts  were  prepared  by  homogenizing either 
washed single cell suspensions or intact tissue. Single cell suspensions were obtained by pushing 
organs through a  wire mesh screen while constantly washing with Eagle's minimum essential 
medium, filtering the suspension through gauze, and then pelleting the cells by centrifugation. 
Erythrocytes were subsequently removed by resuspending the cells in 0.85% ammonium chloride 
for 10  min at 20°C,  and intact cells were removed by centrifugation.  Comparable results were 
obtained  with either  cell  suspensions or  tissue  homogenates,  although extracts  of single  cell 
suspensions interfered less in the assays at high protein concentrations. In either case, an equal 
volume of 1% Triton, 1 M KC1, and 0.1 M sodium phosphate buffer at pH 7.0 was added, and the 
cells or tissues were homogenized with 10 strokes in a  ground glass homogenizer. One volume of 
H=,O was added and the tissue rehomogenized. The extract was then centrifuged at 15,000 rpm for 
20 min, and the supernate aliquoted and frozen at  -20°C for assays. 
Competition radioimmune precipitation assays were comparable to those previously reported 
(11).  Tissue extracts were diluted twofold in 0.2 ml of 0.01% Triton, 0.1 M NaC1, and 0.05 M Tris- 
HC1,  pH 7.5. The necessary concentrations of antisera required to precipitate approximately 50% 
of the  labeled  antigen  of monospecific rabbit  antisera  to  either AKR  murine  leukemia  virus 
(MuLV) gp71, p30, or p12 or a goat antiserum against the endogenous virus of C57L mice (provided 
by Dr. Raymond Gilden of the Frederick Cancer Research Center) and approximately 0.01 ml of 
normal rabbit or goat gamma globulins were added.  The mixtures were incubated 1 h  at 37°C, 
iodinated antigen was added, and the mixtures incubated 3 h at 37°C and overnight at 4°C.  Goat 
antisera to rabbit gamma globulins or rabbit antisera to goat gamma globulins were then added at 
the appropriate concentration to reach the equivalence point for precipitation of the added carrier 
rabbit gamma globulins and incubated 2 h at 37°C and 3 h at 4°C. Immune precipitates were then 
collected by centrifugation, washed once with the above buffer, and counted in a gamma counter. 
l Abbreviations  used in this paper: MuLV, murine leukemia virus(es); TNET, 0.01 M Tris-HC1, 
0.1 M NaC1, 0.001 M EDTA,  and 0.01%  (wt/vol) Triton-X-100, pH 7.5. 424  C-TYPE  VIRAL  GLYCOPROTEINS  IN  NORMAL  MOUSE  TISSUES 
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FIG.  1.  Comparisons of the  reactivities of AKR  MuLV  (e),  BALB(X)  MuLV  (A),  and 
Friend  MuLV  (m)  in  radioimmune  assays  for  the  major  envelope  glycoprotein,  gp71. 
Viruses disrupted in 0.5 M KC1,  0.5% (wt/vol) Triton-X-100, 0.01 M Tris-HC1,  pH 7.5 and 
assayed at serial twofold dilutions in 0.2 ml of TNET for their ability to compete with the 
indicated l-~SI-labeled gp71 at limiting antiserum dilution.  (A) Rabbit anti-AKR gp71,  ~sI- 
labeled AKR gp71.  (B) Goat anti-C57L-MuLV,  125I-labeled  BALB(X) gp71. 
The results are presented as the percent of labeled antigen precipitated relative to that precipi- 
tated in the absence of competing antigen. 
The specificities of the radioimmune competition assays used in these studies are shown in Fig. 
1.  As seen  in  Fig.  1A,  the  assay  for the  AKR-type  MuLV  gp71  is type  specific.  AKR  MuLV 
competes,  whereas neither Friend MuLV nor BALB(X) MuLV competes.  The specificity of the 
assay for the BALB(X) gp71 is shown in Fig. 1 B. In this assay both the NZB (not shown) and the 
BALB(X)  viruses  compete  completely,  whereas  Friend  MuLV  and  AKR  MuLV  compete  only 
partially. The specificities of competition assays for AKR MuLV p30 and p12 have been described 
(8).  Briefly, all murine C-type viruses examined compete completely in the p30 assay,  whereas 
generally only the N-tropic Gross-type viruses compete completely in the p12 assay. 
Preparation  of RNA.  AKR  MuLV  70S  RNA  was  isolated  from  purified  virus  by  phenol 
extraction and sucrose density gradient centrifugation as previously described (9).  Cellular and P.  R.  McCLINTOCK,  J. 
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FIG.  2.  Radioimmune  assays of C57BL/6  tissues for the  MuLV  proteins.  Homogenates 
were prepared from bone marrow (©), lymph node (A), spleen (&), and thymus (I) cells as 
described in the Materials and Methods. Serum ([]) was adjusted to 0.01 (wt/vol) Triton-X- 
100,  and the appropriate purified virus or viral protein was used to generate a  standard 
curve (@). These were serially diluted and reacted as described for Fig.  1.  (A), AKR gp71; 
(B), BALB(X) gp71; (C), AKR p12; (D), AKR p30. For the AKR gp71, AKR p12, and AKR 
p30 standard curves the abscissas are nanograms of competing protein. 
tissue RNAs, prepared from cytoplasmic extracts by phenol extraction, contained intact ribosomal 
RNA with less than 5% DNA contamination. 
DNA-RNA Hybridization.  [3H]cDNA was synthesized in the endogenous reverse transcrip- 
tion reaction with AKR MuLV and purified as previously described (9). The [3H]cDNA product had 
a specific radioactivity of 1-2 ×  107 cpm//~g, and was greater than 99% digestible with nuclease $1. 
At least 90% of the probe hybridized with an excess of AKR MuLV 70S RNA. 
The [3H]cDNA and viral and cellular RNAs were hybridized in 0.45 M NaC1 at 62°C for 48 h. 
The extent of hybridization was assayed with nuclease $1 as described previously (8). The percent 
hybridization is defined as the counts per minute resistant to nuclease $1 digestion divided by the 
total acid-precipitable counts per minute. 
The  thermal  stabilities of the  hybrids  were  measured  by  nuclease  $1  digestion  after  each 
increase in temperature in 0.15 M NaC1. The To is defined as the temperature at which 50% of the 
hybrid tested is rendered sensitive to nuclease $1. 
Results 
The distribution of viral antigens in a variety of tissue extracts and sera from 
C57BL/6 mice was examined by competition radioimmune assays (Fig. 2). In the 
assay for AKR MuLV gp71 most tissues, including lymph node, spleen, thymus, 426  C-TYPE  VIRAL  GLYCOPROTEINS  IN  NORMAL  MOUSE  TISSUES 
or  serum,  contained  no  competing  antigen.  In  contrast,  extracts  from  bone 
marrow cells competed in this assay and with a slope of competition identical to 
that  seen with purified AKR MuLV gp71.  Of the tissues examined,  only sera 
competed in the assay for BALB(X) gp71  (Fig.  2 B) and gave curves with both 
extents  and  slopes of competition  identical  to  those  obtained  with  BALB(X) 
virus. In this assay, however, other tissues including lymph node, the presence 
of thymus, spleen, and bone marrow gave partial competition suggestive of the 
presence of partially  cross-reactive antigens.  The results  obtained with these 
samples in competition assays for p30 and AKR MuLV p12 are shown in Figs. 
2 C  and 2 D.  In assays for p30,  all the tissues examined competed comparably 
and possessed low concentrations  of p30, consistent with previous results  (14, 
15). In contrast,  none of the tissues examined competed in the assay for AKR 
MuLV p12.  These results demonstrate  a  unique expression of an AKR MuLV 
gp71-1ike antigen in bone marrow cells and a BALB(X) gp71-1ike antigen in sera 
without a  comparable increase in the expression of p30. 
Typical results of additional experiments using sera and tissue extracts from 
129/J mice are shown in Fig. 3. Comparable to the results obtained with C57BL/ 
6 mice, only homogenates from 129/J bone marrow cells competed completely in 
the assay for AKR MuLV gp71  (Fig.  3 A) although this particular  lymph node 
extract competed to some extent at high protein concentrations.  Similarly, only 
sera from 129/J mice competed completely in the assay for BALB(X) gp71 (Fig. 
3 B), although the other tissues examined gave incomplete competition. None of 
the tissues competed in the  assay for AKR MuLV p12  (Fig.  3 D),  and  all the 
tissues competed at high protein concentrations in the assay for p30 (Fig.  3 C). 
Therefore, as with C57BL/6 mice, these results suggest the unique expression of 
an AKR MuLV gp71-1ike antigen in bone marrow cells and a BALB(X) gp71-1ike 
antigen  in sera of 129/J mice. 
Typical  results  obtained  with  competition  assays  for  AKR  MuLV  virion 
proteins and homogenates of bone marrow cells from several additional strains 
of mice are  summarized  in  Table I.  All the  homogenates examined  from the 
genus Mus  competed strongly in the assay for AKR MuLV gp71.  Among the 
inbred strains of mice examined, the levels of antigen were comparable with the 
exception of AKR mice which had increased levels due to active replication of 
the virus as demonstrated by the increases in p30 and p12. Of particular interest 
were the  results  obtained  with  NIH Swiss,  C57L,  and  SWR/J mice.  In  bone 
marrow  cells,  these  mice  express  an  antigen  serologically identical  to  AKR 
MuLV gp71, although as in 129/J mice an infectious AKR-type MuLV has never 
been found in these mice. In contrast no competition was seen in assays for the 
AKR MuLV p12, except in AKR mice, and only low levels of p30 were found in 
most of the extracts. 
The  results  obtained  with  homogenates  of bone  marrow  cells  from  Mus 
musculus domesticus (Kent Island), Mus musculus casteneus, and Mus cervico- 
lor  are  illustrated  in  Fig.  4  and  summarized  in  Table  I.  Comparable  to the 
results obtained with the inbred strains of mice, bone marrow extracts competed 
in  the  assay for AKR MuLV  (Fig.  4A)  gp71  and  gave  slopes of competition 
comparable  to  that  obtained  with  AKR  MuLV  gp71.  There  was  only  weak 
competition in the assay for p30 (Fig. 4 C) and no competition in the p12 assay 
(Fig.  4 B) with the exception of one Mus  musculus  casteneus  which had high P.  R.  McCLINTOCK,  J.  N.  IHLE,  AND  D.  R.  JOSEPH  427 
1c~  []  •  ~  C~[~  ~o  A  A  •  B 
60 
~  2o 
z  D 
0  I  I  I 
(,)  (~000  10~  100  ll0  1  011  Q~  1000  100  1'0  1  011 
c  D 
lOO 
80 
60 
4o 
2o 
lO()O  lOO  1'o  1  o11  o.'ol  1(~oo  lOO  1'o  1  o11  o.'ol 
t~g COMPETING  PROTEIN 
FIG.  3.  Radioimmune assays of 129  tissues for the MuLV proteins.  Homogenates  were 
prepared  from bone marrow  (©),  lymph node  (A),  spleen  (&),  and thymus  (11) cells  as 
described in the Materials and Methods. Serum (O) was adjusted to 0.01% (wt/vol) Triton-X- 
100,  and the appropriate virus or viral protein was used to generate a  standard curve (@). 
These  were  serially  diluted  and  reacted  as  described  for  Fig.  1.  (A),  AKR  gp71;  (B), 
BALB(X) gp71;  (C), AKR p12; (D) AKR p30.  For the AKR gp71, AKR p12, and AKR" p30 
standard curves, the abscissas are nanograms of competing protein. 
levels of p30 in both lymph nodes (not shown) and bone marrow. Interestingly 
the lymph node extract of this mouse competed partially in the assay for AKR 
MuLV gp71, but with a slope and extent considerably different from AKR MuLV 
gp71 (not shown). Lastly, no competition was observed in any of  the assays with 
extracts of bone marrow cells from rats. 
The ability of the various tissues to compete in the BALB(X) gp71  assay is 
shown in Table II. In general, only sera competed significantly  in this assay and 
not extracts of spleen, thymus, or bone marrow.  Furthermore, although sera 
from Mus musculus casteneus competed partially in the assay, no competition 
was obtained with sera from Mus cervicolor. Also of  interest was the observation 
that sera from either newborn BALB/c or NIH Swiss mice did not compete, 
although sera from 1- to 2-day-old mice have antigen levels comparable to sera 
from adults (data not shown). 
In order to examine the extent of possible virus replication in bone marrow 
cells, hybridization experiments were done.  As seen in Table III, when AKR 
MuLV cDNA was used to detect AKR MuLV sequences in C57BL/6 cellular 
RNA, all of the tissues examined had concentrations of RNA complementary to 428  C-TYPE VIRAL GLYCOPROTEINS IN  NORMAL MOUSE TISSUES 
TABLE I 
Strain Distribution of AKR MuLV Proteins* in Bone Marrow 
Strain  Age  gp71  p30  p12 
wk 
C57BL/6  7  200  7  < 1 
C3H  11  240  9  <1 
B6C3F~  8  220  16  <1 
BALB/c  8  180  17  <1 
NIH Swiss  8  140  19  <1 
SWR/J  6  240  17  <1 
AKR  8  1400  240  34 
129/J  6  170  5  <1 
C57L  16  200  4  <1 
A/J  8  200  19  < 1 
M.m. casteneus-1  26  270  16  ND§ 
M.m casteneus-2  26  100  96011  ND 
M. cervicolor-1  26  280  17  <1 
M. cervicolor-2  26  740  25  <1 
M.m.  (Kent Isl.)  26  260  35  <1 
Rat  6  5  10  <1 
* The data are expressed as nanograms of the viral protein per milligram of 
total protein in the homogenates. 
$ Except for the  wild mice, which were assayed individually,  pools of bone 
marrow cells from five or more animals were used. 
§ ND, not done. 
II The lymph node cells from this  animal  competed in the AKR gp71 assay; 
however, the  slope and extent  of the reaction  were considerably different 
from those seen with the AKR gp71 and bone marrow extracts. 
AKR MuLV cDNA at 100-fold lower concentrations than in AKR fibroblasts or 
leukemic spleens  actively replicating the  virus.  Also, the thermal stability of 
the hybrids detected with these tissue RNAs was approximately 7°C lower than 
with  the  homologous hybrids.  This  lower  Tm  indicates  a  significant  lack  of 
homology and is comparable to previously reported data (2). Table III shows that 
the  hybrids between  AKR MuLV cDNA and  AT-124 or  BALB(X) viral  RNA 
have a  lower Tm and extent of hybridization when compared to the homologous 
hybrid  with  AKR  MuLV  70S  RNA or tissues  actively replicating  AKR-type 
viruses.  These results  are compatible with the presence of low levels of xeno- 
tropic-like RNA sequences in most C57BL/6 tissues, but more importantly fail to 
detect any overt expression of AKR MuLV-type RNA in bone marrow cells. 
Discussion 
Several previous reports  (4,  5,  16) have suggested the widespread expression 
in mice of glycoproteins of viral origin in the absence of overt virus expression. 
Most  of these  studies  however  used  broadly  reactive  assays  which  detected 
antigens serologically related to the viral glycoprotein, but which did not have 
the specificity to distinguish among the viral glycoproteins of the known endoge- 
nous murine C-type viruses.  In more recent experiments the molecular hetero- 
geneity of this  expression  was indicated by differences in  the tryptic maps of P.  R.  McCLINTOCK,  J.  N.  IHLE~  AND  D.  R.  JOSEPH  429 
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Fro.  4.  Radioimmune assays of feral mouse bone marrow for (A), AKR MuLV gp71;  (B), 
AKR MuLV p12; and (C), AKR MuLV p30. Homogenates were prepared from bone marrow 
cells as described in the Materials and Methods. The homogenates were serially diluted and 
reacted as  described for  Fig.  1.  ([]),  Mus  cervicolor-1;  (A),  Mus  cervicolor-2;  (i),  Mus 
musculus casteneus-1;  (©), Mus musculus casteneus-2;  (O), Mus musculus domesticus  (Kent 
Island,  Md.).  (A),  purified protein standard.  The  abscissas for the standard curves are 
nanograms of competing protein. 
gp71-1ike molecules from various tissues (17, 18). Our results confirm and extend 
these  observations  by demonstrating  that  by using  type-specific competition 
assays  both  virus  and  tissue  specificity  can  be  detected.  Thus,  the  results 
demonstrate the presence of an antigen serologically indistinguishable from the 
AKR MuLV gp71 in bone marrow cells of all mice examined and the presence of 
an antigen serologically indistinguishable from the BALB(X) MuLV gp71 in the 430  C-TYPE  VIRAL  GLYCOPROTEINS  IN  NORMAL  MOUSE  TISSUES 
TABLE  II 
Distribution of BALB(X) gp71  in Murine Tissues* 
Bone mar- 
Strain  Age  Spleen  Thymus  Serum 
row 
wk 
C57BL/6  7  <10  <10  60  <10 
C3H  11  < 10  < 10  100  < 10 
B6C3F1  8  <10  <10  80  <10 
BALB/c  8  < 10  < 10  160  < 10 
BALB/c  Newborn  ND$  ND  <10  ND 
NIH Swiss  8  <10  <10  420  <10 
NIH Swiss  Newborn  ND  ND  <10  ND 
129/J  6  <10  <10  500  <10 
AKR  8  <10  <10  90  <10 
M.m. casteneus-1  26  ND  ND  260  <10 
M. eervicolor-1  26  ND  ND  <10  <10 
* The data are expressed as nanograms of the viral protein per milligram of total 
protein in the homogenates or serum. Sera from three to five mice at the indicated 
age were pooled and used in the assay. Newborn sera were obtained by pooling the 
sera obtained from two litters. 
ND, not done. 
TABLE  III 
Hybridization of C57BL/6 Tissue RNA  with AKR MuLV cDNA 
Source of RNA  CO,~2"  T,,,$  Hybridization§ 
mg/ml  °C  % 
C57BL/6  liver  8.0  74  >38 
C57BL/6  thymus  11  71  >35 
C57BL/6  spleen  <20  72  >30 
C57BL/6  fetal liver  <20  74  >30 
C57BL/6  bone marrow  <20  71  >30 
AKR spleen (leukemic) 
AKR fibroblasts (MuLV)]I 
AKR MuLV 70S RNA 
AT 124 MuLV 70S RNA¶ 
BALB/c xenotropic MuLV** 
0.01  79  92 
0.08  80  90 
0.03  (tzg/ml)  80  90 
0.10  (ug/ml)  73  50 
0.06  76  42 
* CO,,2 is the concentration of RNA required for 50% of maximum hybridization of 
AKR MuLV cDNA. If the maximum hybridization is not known, CO~ is based on 
total counts per minute. 
$ T m  is the temperature at which 50% of the hybird is dissociated in 0.15 M NaC1. The 
deviation for T m values is approximately I°C. 
§ Hybridization is the extent of hybridization at saturation of AKR MuLV cDNA. (>) 
indicates that saturation was not obtained, and the values given are the maximum 
observed percent hybridization. 
I[ AKR fibroblasts were from a  tissue culture cell line that spontaneously initiated 
replication of MuLV. 
AT 124 is a  xenotropic virus isolated from NIH Swiss mice. 
** The cellular RNA obtained from a mink lung cell line infected with a  xenotropic 
virus from BALB/c mice. P.  R.  McCLINTOCK,  J.  N.  IHLE,  AND  D.  R.  JOSEPH  431 
sera of most mice. Interestingly however, neither of these antigens were detect- 
able in  the thymus  of 129/J  mice,  a  site of expression  suggested  in previous 
studies  (5,  19). The  latter  result  might  best be reconciled by the  presence of 
additional  glycoproteins serologically related to the viral  glycoproteins which 
are not detected in our type-specific assays. 
The expression of the AKR MuLV gp71-1ike antigen  in mouse bone marrow 
occurs independent of virus expression by several criteria. First, in bone marrow 
cells there was a  unique expression of the antigen  without any change in the 
"normal" concentration of p30.  Second, by RNA-DNA hybridization, there was 
no increase in AKR MuLV-specific RNA in bone marrow cells relative to spleen 
or thymus and no alteration of the Tm of the hybrids, which might suggest the 
expression of the complete AKR MuLV genome. Lastly, the bone marrow AKR 
MuLV gp71-1ike antigen  is found in mice genetically lacking a  portion of the 
AKR  MuLV  genome  (3).  Because  of this  independence  of expression  from 
complete virus replication we hesitate to conclude that the antigens we detect 
are  coded for by viral  genes.  Thus,  although  the  data  clearly demonstrate  a 
striking  serological  similarity,  we  have  no  data  to  suggest  that  the  tissue 
antigens are coded for by a "viral" gene as opposed to cellular genes. Because of 
this caveat we have referred to the proteins we detected as viral-like antigens. 
The expression of the serum  BALB(X) gp71-1ike antigen  also appears to be 
independent  of virus expression.  This  expression is constitutive in all  strains 
examined and is seen in sera containing  no or low levels of p30. These results 
confirm and extend those reported by Hino et al.  (20). The independent expres- 
sion of this antigen,  however, is hard to assess since we cannot detect its site of 
synthesis.  In particular,  we have no evidence that it is expressed normally in 
spleen,  lymph  node,  or  bone  marrow.  Since  it  is  present  in  serum  and  is 
expressed constitutively in  serum after birth,  the logical conclusion might  be 
that it is a  serum antigen and consequently synthesized in the liver. However, 
the  antigen  was not detected in perfused liver,  suggesting  at  least  a  lack of 
accumulation  in  hepatocytes.  Thus,  although  the  site  of  synthesis  of  the 
BALB(X) gp71-1ike antigen is not known, the available evidence suggests that 
its presence in serum is not due to high levels of endogenous virus expression. 
In  previous  studies  we have  extensively described the  normal  immune  re- 
sponse of mice to the endogenous AKR MuLV-type gp71  (11,  12). The question 
therefore arises whether the expression of the bone marrow AKR MuLV gp71- 
like antigen  is immunogenic in this response and/or whether such mouse sera 
are reactive with this antigen.  In terms of the latter question, we have no data 
yet concerning the ability of normal mouse sera to react with this antigen.  In 
terms of the immunogenic properties of the bone marrow expression, the availa- 
ble evidence suggests that it is not responsible for the immune response against 
AKR  MuLV  gp71.  In  particular,  the  development  of an  immune  response 
against AKR MuLV gp71 has been shown to be both strain and age dependent, 
the differences being related to the spontaneous expression of the endogenous 
virus (21).  In contrast, the AKR MuLV gp71-1ike antigen associated with bone 
marrow  cells  is  both  strain  and  age  independent  in  its  expression  (data  not 
shown).  Other  studies from our laboratory have also demonstrated  indirectly 
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of highly type-specific antisera  against  AKR MuLV gp71 to inhibit  mitogenic 
responses  (22). This  expression,  however,  was completely correlated  with  an 
immune response against the virus and with the ability to express endogenous 
AKR MuLV.  Thus,  both virus-independent  and virus-dependent,  biologically- 
specific and site-specific expression of AKR MuLV gp71-1ike antigens have been 
detected. 
It is particularly  interesting  that  the  bone marrow  expression of the  AKR 
MuLV gp71-1ike antigen  is constitutive in all strains  of mice examined and is 
highly conserved evolutionarily as demonstrated by the presence of a  serologi- 
cally  identical  antigen  in  Mus  cervicolor.  These  properties  taken  together 
suggest that this expression may be required for either differentiation or normal 
cellular function.  Although our experiments do not directly address this ques- 
tion,  the  availability of monospecific antisera  highly  specific for this  antigen 
will provide the basis for future experiments to define the biological properties of 
the  cells expressing this  antigen.  In particular,  the  cell types expressing the 
AKR MuLV gp71-1ike  antigen  in bone marrow  need to be identified  and  the 
question  of intracellular  versus  cell  surface  expression needs to be resolved. 
These types of studies should help to better define the relationship  of endoge- 
nous virus expression to both pathogenesis and normal cellular function. 
Summary 
By  competition  radioimmune  assays  with  antisera  against  AKR  murine 
leukemia virus (MuLV) gp71 or antisera against xenotropic virus, and iodinated 
AKR MuLV  gp71  or BALB(X) gp71,  antigens  serologically indistinguishable 
from the viral antigens can be detected in tissues of normal mice in the absence 
of overt virus expression. An antigen serologically indistinguishable from AKR 
MuLV gp71 can be readily detected in normal bone marrow cells of the common 
strains  of mice  including  NIH Swiss,  129/J,  and  SWR/J,  as  well  as  in  Mus 
cervicolor and Mus musculus casteneus.  In contrast, this antigen is not detected 
in normal spleen, thymus, lymph nodes, or serum. 
Similarly, an antigen serologically indistinguishable from BALB(X) gp71 was 
found in all normal mouse sera examined. This antigen was not present in fetal 
liver, perfused adult liver, thymus, spleen, lymph nodes, or bone marrow of the 
mice examined. An equivalent antigen was detected in sera from Mus musculus 
casteneus but not in sera from Mus cervicolor. 
Received for publication  18 April 1977. 
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